Victoria Bunik | Biology | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Victoria Bunik

Victoria Bunik
Affiliation Moscow State University
Country Russia
Scopus ID 7003933084
Documents 130
Citations 3,738
h-index 32
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0002-2552-8560

Victoria Bunik is a researcher associated with biological sciences and neurochemical research at Moscow State University. Her scholarly work includes studies on metabolic regulation, mitochondrial biochemistry, neurodegenerative mechanisms, vitamin-dependent biochemical pathways, and molecular neurobiology.[1] Her publications demonstrate sustained contributions to biochemical and neurological research through interdisciplinary scientific investigations involving enzymatic regulation, metabolic disorders, and molecular therapeutic approaches.

Abstract

Victoria Bunik has contributed extensively to biological and neurochemical sciences through research involving mitochondrial metabolism, enzymatic regulation, vitamin-dependent biochemical processes, and neurological disorders. Her publications examine molecular mechanisms associated with epilepsy, neurodegeneration, metabolic adaptation, and cellular signaling pathways.[2] Her interdisciplinary studies integrate biochemical analysis with molecular biology approaches to investigate metabolic homeostasis and neurological function. The research output demonstrates sustained academic engagement in neurochemistry and molecular biology, contributing to scientific understanding of metabolic regulation and potential therapeutic pathways in complex neurological and biochemical disorders.

Keywords

Biology, Neurochemistry, Molecular Biology, Metabolic Regulation, Mitochondrial Biochemistry, Neurological Disorders

Introduction

Modern biological research increasingly focuses on understanding metabolic regulation and molecular signaling in neurological systems. Scientific investigations involving mitochondrial function and vitamin-dependent enzymatic activity are important for advancing biomedical knowledge.[3] Victoria Bunik’s work contributes to this area through studies examining neurochemical and biochemical pathways.

Research Profile

Her research profile reflects extensive publication activity in biology and neurochemistry with an h-index of 32 and more than 3,700 citations. Her academic contributions include journal articles and collaborative studies involving molecular biology, epilepsy research, mitochondrial metabolism, and vitamin-related biochemical regulation.[1]

Research Contributions

Victoria Bunik has contributed to studies involving pyruvate dehydrogenase regulation, protein acylation, epilepsy-related metabolism, and neurochemical responses to vitamins B1 and B6.[4] Her work also includes investigations into glutamate dehydrogenase activity and biochemical markers associated with neurological conditions.

Publications

  • “Pentylenetetrazole-Induced Seizures Are Increased after Kindling.”
  • “Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase.”
  • “Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.”

Research Impact

The research conducted by Victoria Bunik contributes to scientific understanding of neurochemical regulation and metabolic adaptation in neurological systems. Her work has relevance for molecular medicine, neurodegenerative disease research, epilepsy studies, and biochemical therapeutic investigations.[5]

Award Suitability

Victoria Bunik’s sustained publication record, interdisciplinary biological research, and scholarly impact demonstrate suitability for recognition through the Innovative Research Award. Her scientific contributions support continued advancement in neurochemistry, metabolic biology, and molecular biomedical sciences.

Conclusion

The academic work of Victoria Bunik reflects consistent engagement in biological and neurochemical sciences through studies focused on metabolic regulation, molecular signaling, and neurological processes. Her research contributions continue to support scientific progress in molecular biology and neurochemistry.

References

  1. Elsevier. (n.d.). Scopus author details: Victoria Bunik, Author ID 7003 933084. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003933084
  2. Bunik, V. et al. (2023). Pentylenetetrazole-Induced Seizures Are Increased after Kindling. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms241512405
  3. ORCID. (2026). Victoria Bunik Research Record.
    https://orcid.org/0000-0002-2552-8560
  4. Bunik, V. et al. (2022). Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase. Journal of Neurochemistry.
    https://doi.org/10.1111/jnc.15576
  5. Bunik, V. et al. (2010). Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.
    https://doi.org/10.4061/2010/749061

Alisa Kokorina | Biology | Women Researcher Award

Published on by Scientific World Research Awards

Women Researcher Award

Alisa Kokorina

Alisa Kokorina, affiliated with the Skolkovo Institute of Science and Technology, is a researcher recognized for contributions to biology, neurotechnology, and post-COVID-19 clinical outcome research. Her scholarly activities reflect interdisciplinary collaboration involving rehabilitation technologies, neuroscience, and international healthcare consensus studies.[1]

Alisa Kokorina
Affiliation Skolkovo Institute of Science and Technology
Country Russia
Scopus ID 57438603500
Documents 2
Citations 288
h-index 2
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0001-5325-5830

Her publications address rehabilitation science, clinical outcome standardization, and brain-computer interface methodologies. Through participation in international Delphi consensus initiatives, Kokorina has contributed to the development of standardized approaches for studying post-COVID-19 conditions and rehabilitation outcomes.[2]

Abstract

Alisa Kokorina is associated with interdisciplinary scientific research focusing on biology, neurotechnology, and clinical rehabilitation studies. Her scholarly work includes participation in international investigations related to post-COVID-19 condition assessment and the development of standardized clinical outcome sets. She has contributed to research on brain-computer interface technologies and lower limb rehabilitation systems integrating electrical spinal stimulation methodologies. Publications connected to her research profile appear in internationally recognized journals such as The Lancet Respiratory Medicine, BMC Medicine, and Frontiers in Human Neuroscience. These contributions demonstrate collaborative engagement in evidence-based healthcare and rehabilitation science research initiatives.[2]

Keywords

Biology, Neurotechnology, Brain-Computer Interface, Rehabilitation Science, Post-COVID-19 Research, Clinical Outcomes, Neuroscience, Delphi Consensus.

Introduction

The increasing integration of neurotechnology and healthcare analytics has expanded interdisciplinary biomedical research. Alisa Kokorina has participated in collaborative studies involving rehabilitation systems, neuroscience, and post-COVID-19 clinical frameworks. Her research activity reflects the importance of international scientific cooperation in addressing rehabilitation and long-term healthcare challenges.[3]

Research Profile

Kokorina’s academic profile includes publications indexed through ORCID and Scopus databases. Her documented research areas involve neurorehabilitation systems, post-stroke rehabilitation, and consensus-based clinical outcome measurement studies. She is affiliated with international collaborative research involving medical and rehabilitation sciences.[1]

Research Contributions

Among her noted contributions is participation in studies examining core outcome measurement instruments for adults with post-COVID-19 conditions. Additional work explored rehabilitation methods using visuomotor transformation-based brain-computer interfaces and spinal cord electrical stimulation technologies.[4]

Publications

  • Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface, Frontiers in Human Neuroscience, 2026.
  • A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research, Lancet Respiratory Medicine, 2022.
  • Novel method for lower limb rehabilitation based on brain-computer interface and transcutaneous spinal cord electrical stimulation, CNN Conference Proceedings, 2022.

Research Impact

The citation record associated with Kokorina’s research profile indicates scholarly visibility within rehabilitation and biomedical research communities. Her collaborative publications support the advancement of standardized methodologies and interdisciplinary rehabilitation research approaches.[5]

Award Suitability

The Women Researcher Award recognizes emerging and established researchers contributing to scientific innovation and collaborative advancement. Kokorina’s involvement in neurotechnology, rehabilitation science, and post-COVID-19 outcome studies demonstrates interdisciplinary engagement aligned with the objectives of international scientific recognition programs.

Conclusion

Alisa Kokorina’s academic profile reflects contributions to biomedical and rehabilitation sciences through collaborative international research. Her participation in consensus studies and neurotechnology-based rehabilitation investigations highlights ongoing engagement with contemporary healthcare and biological research challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Alisa Kokorina, Author ID 57438603500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57438603500
  2. ORCID. (2026). Alisa Kokorina ORCID Record.
    https://orcid.org/0000-0001-5325-5830
  3. Munblit, D. et al. (2022). A core outcome set for post-COVID-19 condition in adults. Lancet Respiratory Medicine.
    https://doi.org/10.1016/S2213-2600(22)00169-2
  4. Ninenko, I. et al. (2022). Novel method for lower limb rehabilitation based on brain-computer interface.
    https://doi.org/10.1109/cnn56452.2022.9912550
  5. Kokorina, A. et al. (2026). Case Report: post-stroke rehabilitation with a visuomotor transformation-based brain-computer interface.
    https://doi.org/10.3389/fnhum.2026.1774409

Xu-hua Wang | Biotechnology | Research Excellence Award

Published on by Scientific World Research Awards

Assoc. Prof. Dr. Xu-hua Wang | Biotechnology | Research Excellence Award

Zhejiang University, China

Dr. Xuhua Wang is an accomplished researcher recognized for influential contributions to neuroscience, regenerative medicine, spinal cord injury repair, and advanced biomedical technologies. Affiliated with Zhejiang University, Dr. Wang has established a distinguished scientific reputation through innovative studies integrating neural regeneration, biomaterials, gene delivery, and artificial intelligence-based therapeutic design. Their scholarly achievements include 2,855 citations, an h-index of 23, and an
i10-index of 27, reflecting sustained academic impact and international recognition. Dr. Wang’s publications in prestigious journals such as Nature, Cell, and Neuron demonstrate excellence in translational neuroscience and clinical innovation. Through collaborations with renowned global scientists and institutions, the researcher has contributed significantly to advancing functional recovery therapies and neural circuit restoration. Their interdisciplinary expertise continues to influence emerging biomedical strategies aimed at improving neurological healthcare and regenerative treatment methodologies worldwide.

Professional Profile

Education

Dr. Xuhua Wang possesses a strong interdisciplinary academic foundation in neuroscience, biomedical engineering, regenerative medicine, and molecular therapeutics. Their educational development reflects extensive specialization in neural regeneration, fluorescence bioimaging, drug delivery systems, and advanced translational biomedical research. Through academic training and continuous scientific engagement, Dr. Wang cultivated expertise in corticospinal circuitry, neurobiology, nanotechnology-assisted therapeutics, and biomaterials engineering. Association with Zhejiang University further strengthened their research-oriented academic background and exposure to high-level scientific innovation. The combination of theoretical knowledge and laboratory-based experience has enabled Dr. Wang to pursue groundbreaking investigations addressing spinal cord injury recovery and emerging therapeutic technologies in neuroscience.

Professional Experience

Dr. Xuhua Wang has accumulated extensive research experience in neuroscience, regenerative medicine, and biomedical innovation through collaborations with internationally recognized institutions and scientists. Their professional journey includes contributions to spinal cord injury repair, neural pathway reconstruction, advanced hydrogel development, and targeted therapeutic delivery systems. Collaborative research associations with Boston Children’s Hospital and other leading biomedical centers have enhanced their scientific exposure and interdisciplinary expertise. Dr. Wang has actively participated in high-impact experimental studies involving neural regeneration, AI-assisted biomedical applications, and translational medicine. Their professional experience demonstrates strong leadership in conducting innovative research with significant clinical and scientific relevance.

Research Interest

Dr. Xuhua Wang’s research interests focus primarily on spinal cord injury repair, stroke rehabilitation, neural regeneration, biomaterials engineering, and targeted drug and gene delivery systems. Their investigations explore corticospinal tract regeneration, extracellular vesicle therapies, hydrogel-based neural repair technologies, and advanced fluorescence bioimaging techniques. Additionally, Dr. Wang demonstrates growing interest in integrating artificial intelligence for AAV capsid engineering and precision therapeutic design. The interdisciplinary nature of their research combines neuroscience, nanomedicine, molecular biology, and biomedical engineering to develop innovative treatment approaches for neurological disorders. Their scientific interests continue to contribute toward improving functional recovery and regenerative healthcare strategies worldwide.

Award and Honor

Dr. Xuhua Wang has earned significant academic recognition through a highly influential publication record, exceptional citation performance, and impactful scientific contributions in neuroscience and regenerative medicine. With 2,855 total citations, 1,594 citations since 2021, an h-index of 23, and an i10-index of 27, Dr. Wang demonstrates sustained international scholarly influence. Publications in prestigious journals including Nature, Cell, and Nature Communications reflect the quality and significance of their research achievements. Their scientific accomplishments and collaborations with globally recognized researchers highlight professional excellence, innovation, and outstanding contributions to translational neuroscience and biomedical advancement.

Conclusion

Dr. Xuhua Wang has demonstrated exceptional scientific excellence through impactful research in neuroscience, regenerative medicine, and biomedical engineering. Their influential publications, strong citation metrics, and innovative interdisciplinary contributions highlight significant global academic impact. Dr. Wang continues to advance translational healthcare research with remarkable dedication, innovation, and scientific leadership.

Publications Top Noted

Title: Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury
Authors: K Zukor, S Belin, C Wang, N Keelan, X Wang, Z He
Year: 2013
Citation: 346

Title: Touch and tactile neuropathic pain sensitivity are set by corticospinal projections
Authors: Y Liu, A Latremoliere, X Li, Z Zhang, M Chen, X Wang, C Fang, J Zhu, et al.
Year: 2018
Citation: 288

Title: Deconstruction of corticospinal circuits for goal-directed motor skills
Authors: X Wang, Y Liu, X Li, Z Zhang, H Yang, Y Zhang, PR Williams, et al.
Year: 2017
Citation: 245

Title: Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3
Authors: D Jin, Y Liu, F Sun, X Wang, X Liu, Z He
Year: 2015
Citation: 231

Title: A sensitized IGF1 treatment restores corticospinal axon-dependent functions
Authors: Y Liu, X Wang, W Li, Q Zhang, Y Li, Z Zhang, J Zhu, B Chen, PR Williams, et al.
Year: 2017
Citation: 225

 

Sophia Zachari | Biotechnology | Research Excellence Award

Published on by Scientific World Research Awards

Mrs. Sophia Zachari | Biotechnology | Research Excellence Award

PhD Candidate | University of Thessaly | Greece

Mrs. Sophia Zachari is a researcher at University of Thessaly, specializing in biomedical and genetic research. Her interests include genomics, immunology, and treatment response analysis, particularly in psoriasis studies. She demonstrates strong skills in genome-wide association studies and molecular data analysis. Her contributions are gaining recognition through emerging publications and collaborations. According to Scopus, she has 2 citations, 2 documents, and an h-index of 1, reflecting her growing research impact.

 

Citation Metrics (Scopus)

2
1.5
1
0.5
0

Citations

2

Documents

2

h-index

1

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Bushra Bushra | Biology | Research Excellence Award

Published on by Scientific World Research Awards

Dr. Bushra Bushra | Biology | Research Excellence Award

Post-doctoral researcher | Shantou University Medical College | China

Dr. Bushra Bushra is a postdoctoral researcher focused on fisheries science, parasitology, and molecular biology, with expertise in aquatic disease management. Her research centers on Cryptocaryon irritans, advancing detection and antiparasitic strategies in aquaculture. She is skilled in PCR, transcriptomics, and metabolomics, contributing to impactful scientific publications. She has earned recognition through her research contributions. According to Scopus, she has 31 citations, 6 documents, and an h-index of 3, reflecting her growing academic influence.

 

Citation Metrics (Scopus)

31
25
15
5
0

Citations

31

Documents

6

h-index

3

Citations

Documents

h-index

View Google Scholar Profile View ResearchGate Profile

Featured Publications

 

Hengbin Wang | Biology | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Hengbin Wang | Biology | Research Excellence Award

PhD | Virginia Commonwealth University | United States

Prof. Hengbin Wang is a highly accomplished biomedical researcher specializing in epigenetics, chromatin biology, and cancer molecular mechanisms, with a strong focus on how chromatin remodeling and histone modifications regulate gene expression, genome stability, and disease progression. His research interests include Polycomb repressive complexes (PRC1), histone ubiquitination and methylation, chromatin remodelers such as RSF1, non-coding RNAs, mitochondrial regulation, and translational cancer biology, particularly in esophageal and pancreatic cancers. He possesses advanced research skills in molecular and cellular biology, epigenomic analysis, cancer genomics, functional assays, therapeutic target validation, and drug-sensitization strategies. Prof. Wang’s scientific excellence has been recognized through competitive research grants, high-impact publications, and international peer recognition, reflecting notable awards and professional honors in his field. According to Scopus, he has authored 70 documents, received 11,684 citations, and holds an h-index of 32, underscoring his significant and sustained research impact. Overall, his work bridges fundamental chromatin regulation with clinically relevant cancer therapeutics and precision medicine.

 

Citation Metrics (Scopus)

11684
9000
6000
3000
1000
500
100
0

Citations

11,684

Documents

70

h-index

32

Citations

Documents

h-index

View Scopus  View Google Scholar View ResearchGate

Featured Publications

 

Aniket Gade | Biology | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Aniket Gade | Biology | Best Researcher Award

Associate Professor | Institute of Chemical Technology | India

Dr. Aniket Krishnarao Gade, affiliated with the Institute of Chemical Technology, Mumbai, India, is a prominent researcher in nanotechnology, green chemistry, and sustainable agriculture. He has earned recognition for his extensive contributions to eco-friendly synthesis of metallic and metal-oxide nanoparticles using plant extracts and microbial systems, advancing applications in environmental remediation, crop protection, and biomedical fields. Dr. Gade’s educational background includes a strong foundation in chemical technology and nanoscience, enabling him to integrate interdisciplinary approaches in his research. Professionally, he has developed multifunctional nanomaterials such as Ag-doped ZnO and iron oxide nanoparticles for photocatalytic degradation of environmental pollutants, antimicrobial and antifungal activity, and anticancer therapies, while also exploring innovative solutions in sustainable agriculture through carbon nanodots and pycnidia-forming fungi to enhance crop yield, fertilizer efficiency, and pest management with minimal ecological impact. His research interests encompass nanomaterial synthesis, theranostic nanomedicine, environmental nanotechnology, and agricultural nanobiotechnology, reflecting a commitment to solving real-world challenges through sustainable science. Dr. Gade possesses advanced research skills in nanoparticle fabrication, characterization techniques, biosensor development, and interdisciplinary experimental design, demonstrating a balance of fundamental and applied expertise. Throughout his career, he has received multiple awards and honors recognizing his scientific innovation and impact in nanotechnology and green chemistry. With a prolific record of 122 documents indexed in Scopus, over 15,234 citations, and an h-index of 43, his work has influenced a broad spectrum of scientific studies and applications. In conclusion, Dr. Gade’s career exemplifies a harmonious blend of research excellence, innovation, and societal relevance, making him a leading figure in sustainable nanotechnology and its applications in agriculture, environment, and human health.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Sah, P. M., Gite, S. G., Naik, H. S., Sonawane, R., Nadrowska, J., Golińska, P., Raut, R. W., & Gade, A. K. (2025). Ag-doped ZnO nanoparticles: A versatile multifunctional nanomaterial for anticancer, antibacterial, and recyclable photocatalyst. IEEE Transactions on NanoBioscience.

  2. Rai, M., Shende, S. S., Gade, A. K., Prokisch, J., & Avila-Quezada, G. D. (2025). Carbon nanodots for crop protection and fertilizer use in agriculture. BioNanoScience.

  3. Deshmukh, F., Kiran, K., Pawar, S. V., Nawani, N., Golińska, P., Gade, A., Ingle, P., & Gaikwad, S. C. (2025). Efficient photocatalytic degradation of azo dyes using Achyranthes aspera-mediated magnetic iron oxide nanoparticles: A green synthesis approach. Sustainable Chemistry for the Environment.

  4. Raut, R. W., Naik, H. S., Sah, P. M., Golińska, P., & Gade, A. (2025). A comparative analysis of optical biosensors for rapid detection of SARS‐CoV‐2 and influenza. Biotechnology and Bioengineering.

  5. Shende, S. S., Gade, A. K., Minkina, T. M., Ingle, P. U., Rajput, V. D., Sushkova, S. N., Mandzhieva, S. S., Rai, M., & Wong, M. H. (2024). Exploring sustainable management by using green nano-silver to combat three post-harvest pathogenic fungi in crops. Discover Nano.